Overview
Non-epileptic myoclonus encompasses a spectrum of conditions characterized by involuntary movements that mimic epileptic seizures but lack the corresponding electroencephalographic (EEG) abnormalities. This category includes psychogenic nonepileptic seizures (PNES) and nondystrophic myotonias (NDMs), each driven by distinct pathophysiological mechanisms. PNES are often rooted in psychological stressors, particularly evident in scenarios like sports-related trauma, while NDMs arise from genetic mutations affecting muscle ion channels. Understanding the specific etiology is crucial for accurate diagnosis and tailored management strategies. Clinicians must be vigilant in distinguishing these conditions from epileptic disorders to ensure appropriate treatment and support for patients.
Pathophysiology
Psychogenic Nonepileptic Seizures (PNES)
PNES are paroxysmal episodes that mimic epileptic seizures but are not associated with epileptiform EEG activity. The pathophysiology of PNES is multifaceted, involving complex interactions between psychological factors and neurological processes. Psychological stressors, such as competition anxiety in athletes, can precipitate PNES, as evidenced by a case study where a judo athlete experienced immediate onset of PNES following a minor head injury during a contest [PMID:42021088]. This temporal association suggests that acute psychological trauma may trigger PNES, highlighting the significant role of mental health in their onset and perpetuation. In clinical practice, addressing underlying psychological issues through psychotherapy and support can be pivotal in managing PNES.
Nondystrophic Myotonias (NDMs)
NDMs are characterized by muscle membrane hyperexcitability due to genetic mutations affecting ion channels. Mutations in the voltage-gated skeletal muscle sodium channel (SCN4A) and chloride channel (CLCN1) genes are primary culprits. SCN4A mutations lead to sodium channelopathies, such as paramyotonia congenita (PMC), where symptoms like muscle stiffness and cramps worsen with activity and cold exposure [PMID:32270509]. Conversely, CLCN1 mutations result in chloride channelopathies, such as myotonia congenita, often presenting with muscle stiffness that improves with activity, known as the warm-up phenomenon. These genetic alterations disrupt normal muscle excitability, leading to symptoms like muscle stiffness, cramps, weakness, fatigue, and pain. The clinical presentation varies based on the specific channelopathy, necessitating genetic testing for definitive diagnosis and tailored management approaches.
Epidemiology
PNES have a notable impact on clinical practice, with an annual incidence ranging from 1.5 to 6.17 cases per 100,000 individuals, making them a significant contributor to neurology referrals, particularly in emergency departments and among patients presenting with their first seizure [PMID:39841074]. This high referral rate underscores the diagnostic challenges and the need for thorough evaluation to differentiate PNES from epileptic seizures. In contrast, NDMs, while less common in terms of population prevalence, present unique challenges due to their chronic nature and impact on quality of life. The rarity of these conditions means that epidemiological data are often limited, but their clinical significance cannot be understated, especially given the lifelong management required for affected individuals.
Clinical Presentation
Psychogenic Nonepileptic Seizures (PNES)
PNES are characterized by episodes that mimic epileptic seizures but lack epileptiform EEG patterns. Patients often report subjective changes in consciousness, such as altered awareness or detachment, alongside involuntary movements like falling, limb jerking, or vocalizations [PMID:39841074]. These episodes are frequently accompanied by comorbid psychiatric conditions, including anxiety, depression, and post-traumatic stress disorder (PTSD), reflecting the deep psychological underpinnings of PNES. The clinical presentation can be highly variable, making a thorough psychiatric evaluation essential alongside neurological assessment to rule out epileptic causes.
Nondystrophic Myotonias (NDMs)
NDMs present with a distinct set of symptoms primarily affecting skeletal muscle function. Patients commonly experience muscle stiffness or cramps, particularly in the lower limbs, which can be exacerbated by rest and relieved by activity (warm-up phenomenon in chloride channelopathies) [PMID:32270509]. Sodium channelopathies like PMC often manifest with symptoms that worsen with cold exposure and physical activity, leading to episodes of severe muscle stiffness and pain. Fatigue and generalized weakness are also prevalent, impacting daily activities and quality of life significantly. The variability in symptom presentation based on the specific genetic mutation underscores the importance of detailed clinical history and targeted diagnostic testing.
Diagnosis
Psychogenic Nonepileptic Seizures (PNES)
Accurate diagnosis of PNES relies heavily on comprehensive clinical evaluation and diagnostic tools. Video-electroencephalographic (V-EEG) monitoring is a cornerstone in distinguishing PNES from epileptic seizures, as it allows simultaneous observation of clinical events and EEG activity [PMID:42021088]. In the case of the judo athlete, early V-EEG monitoring facilitated prompt diagnosis and initiated appropriate psychological interventions. Additionally, the absence of epileptiform discharges on EEG, combined with a detailed psychiatric evaluation, is crucial. Clinicians should also consider the patient's history for psychological stressors and trauma, which can provide critical clues.
Nondystrophic Myotonias (NDMs)
Diagnosing NDMs involves a combination of clinical assessment and genetic testing. Clinical features such as the warm-up phenomenon in chloride channelopathies and cold-induced symptoms in sodium channelopathies guide initial suspicion [PMID:32270509]. Electromyography (EMG) can reveal characteristic myotonic discharges, supporting the diagnosis. Genetic testing for mutations in SCN4A and CLCN1 genes is definitive but may not always be immediately available. In clinical practice, distinguishing NDMs from dystrophic myotonias, which involve progressive muscle wasting, is essential. The absence of muscle wasting and the presence of specific ion channel mutations help differentiate NDMs from conditions like myotonic dystrophy types 1 and 2.
Differential Diagnosis
Differentiating PNES from posttraumatic epilepsy (PTE) can be challenging, especially when seizures occur shortly after trauma. While PTE typically follows a more predictable temporal pattern with epileptiform EEG changes, PNES onset can be immediate and lacks such EEG abnormalities [PMID:42021088]. Clinicians must carefully evaluate the patient's psychological state and history of trauma to rule out PNES. For NDMs, distinguishing from dystrophic myotonias is critical, as the latter involves progressive muscle wasting and systemic involvement, whereas NDMs are confined to skeletal muscle dysfunction without progressive wasting [PMID:32270509]. Comprehensive genetic testing and clinical correlation are indispensable in making these distinctions.
Management
Psychogenic Nonepileptic Seizures (PNES)
Management of PNES focuses on addressing both psychological and behavioral aspects. Psychotherapy, particularly cognitive-behavioral therapy (CBT), has shown promise in reducing PNES frequency and improving associated psychiatric symptoms like depression and anxiety [PMID:39841074]. A randomized controlled trial demonstrated that the Modified Atkins Diet (MAD) significantly reduced PNES frequency, depression, and anxiety levels compared to a control diet, suggesting dietary interventions as adjunctive therapies [PMID:39841074]. Integrating psychological support into the treatment plan, especially for athletes or individuals with recent trauma, can be highly beneficial in managing PNES and promoting recovery.
Nondystrophic Myotonias (NDMs)
Treatment for NDMs aims to alleviate symptoms and improve quality of life, given the chronic nature of these conditions. Pharmacological interventions, including mexiletine for sodium channelopathies and dichloroacetate for chloride channelopathies, can help manage muscle stiffness and cramps [PMID:32270509]. Quality of life measures in NDMs often mirror those seen in myotonic dystrophy, indicating a significant impact on daily functioning that justifies aggressive symptom management. Lifestyle modifications, such as avoiding cold exposure and engaging in regular, gentle exercise, can also mitigate symptoms. Genetic counseling is recommended for patients and families to understand the hereditary aspects and potential future implications.
Integrated Approach
Given the multifaceted nature of both PNES and NDMs, an integrated approach combining medical, psychological, and supportive therapies is essential. For PNES, early identification and psychological intervention are key, complemented by dietary modifications like MAD when appropriate [PMID:39841074]. In NDMs, timely genetic diagnosis and pharmacological management alongside supportive care can significantly enhance patient outcomes. The availability and timely administration of advanced diagnostic tools, such as E-EEG, play a crucial role in facilitating prompt and accurate diagnosis, thereby influencing clinical decision-making positively [PMID:11435807].
Prognosis & Follow-up
Psychogenic Nonepileptic Seizures (PNES)
While preliminary studies suggest promising outcomes with psychological interventions and dietary modifications, larger, longitudinal studies are needed to confirm these findings and establish standardized treatment protocols [PMID:39841074]. Regular follow-up is crucial to monitor symptom progression, adjust treatment plans as necessary, and provide ongoing psychological support. Long-term prognosis can vary widely depending on the patient's engagement with therapy and the effectiveness of the management strategies employed.
Nondystrophic Myotonias (NDMs)
The prognosis for NDMs is generally stable but requires lifelong management to control symptoms and maintain quality of life. Regular monitoring and adjustments to pharmacological treatments are essential to manage evolving symptoms effectively [PMID:32270509]. Genetic counseling and support groups can also provide valuable resources for patients and families, enhancing coping mechanisms and overall well-being. Long-term follow-up should focus on symptom control, functional status, and psychological support to address the chronic nature of these conditions.
Key Recommendations
References
1 Janssen-Aguilar R, la Portilla JG, Martínez-Juárez IE, Mimiaga-Hernandez C, Alvarado-Luis G, Aguilar-Hernandez A et al.. The impact of ketogenic diet on the frequency of psychogenic non-epileptic seizures (PNES): A feasibility randomized pilot study. Epilepsia open 2025. link 2 Stunnenberg BC, LoRusso S, Arnold WD, Barohn RJ, Cannon SC, Fontaine B et al.. Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle & nerve 2020. link 3 Kikuchi A, Yokosako S, Ujiie H, Nishiyama K, Kubota Y. Prolonged Psychogenic Non-epileptic Seizures Manifested Immediately after Minor Sport-related Head Injury in a Young Judo Athlete:A Case Report. The journal of medical investigation : JMI 2026. link 4 Quigg M, Shneker B, Domer P. Current practice in administration and clinical criteria of emergent EEG. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2001. link